Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : STEM -- StemCells, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (298)	8/2/1999 12:28:00 PM
From: Jon Koplik	Read Replies (1) \| Respond to of 805

My limited experience with biotech stocks (CTII, Human Genome Sciences, and Entremed) has been that (I think) the trading action in these types of stocks has been even more "wacko" than that of the other (main) thing I am involved with (wireless stocks). I just do not want to be involved with something so nutso. I would not be surprised if all three of the biotech stocks I just mentioned are much higher in price in the medium to long run; and the implications for all of us with regard to medical stuff is a lot more important than "removing some money" from the securities markets. Jon.